• Text Resize A A A
  • Print Print
  • Share Share on facebook Share on twitter Share

September 2018 NVAC Meeting

September 12, 2018 - September 13, 2018

The Great Hall, Humphrey Building
200 Independence Avenue S.W.
Washington, DC 20201

Agenda

Wednesday, Sept. 12

Time Agenda Item Presenter(s)
9:00 – 9:05 a.m. Call to Order and Rules of Engagement Ann Aikin, Acting Designated Federal Official, NVAC
9:05 – 9:20 a.m. Chair’s Welcome Dr. Kimberly Thompson, NVAC Chair
9:20 – 9:30 a.m. NVPO Update Dr. Tammy Beckham, Acting Director, NVPO
9:30 – 9:45 am Opening Remarks ADM Brett P. Giroir, Assistant Secretary for Health, OASH
9:45 – 10:15 a.m. Igniting Advances in Immunization: Funding Unmet Needs Dr. Roula Sweis, NVPO
10:15 - 10:30 a.m. Break  
10:30 a.m. – 12:00 p.m. Valuing Vaccines: Direct and Indirect Costs

Dr. Sachiko Ozawa, University of North Carolina School of Pharmacy

Dr. Kent Kester, Sanofi Pasteur

Dr. Kimberly Thompson, Kid Risk, Inc.

12:00 – 1:00 p.m. Lunch  
1:00 – 2:30 p.m. Leveraging Public-Private Partnerships to Move the Needle in Product Development

Phyllis Arthur, Biotechnology Innovation Organization (BIO)

Dr. Annie Mo, NIH

Dr. Linda Lambert, BARDA

Dr. David Kaslow, PATH

Dr. Tim Cooke, NovaDigm Therapeutics

Joanna Wolkowski, Pfizer

2:30 – 3:00 p.m. Break  
3:00 – 3:30 p.m. Online Exchanges about Immunization: the Good, the Bad, and the Ugly Dr. David Broniatowski, George Washington University
3:30 – 3:45 p.m. Special Agency Highlight Presentation Tiffany Tate, NACCHO
3:45 – 4:15 p.m. Liaison Updates ACCV, AHIP, AIM, AIRA, ASTHO, NACCHO, PHAC
4:14 – 4:45 p.m. Ex Officio Updates CDC, DoD, FDA, HRSA, NIH, USDA
4:45 – 5:15 p.m. Public Comment  
5:15 p.m. Adjourn  

 

Thursday, Sept. 13

Time Agenda Item Presenter(s)
9:00 – 9:05 a.m. New Chair’s Welcome Dr. Robert Hopkins, NVAC Chair
9:15 – 10:45 a.m. Exploring the Pipeline: CMV Vaccines

Dr. Tatiana Lanzieri, CDC

Dr. Cristina Cassetti, NIAID

Dr. Philip Krause, FDA

10:45 – 11:15 a.m. Break  
11:15 a.m. – 12:15 p.m. Advances in Vaccination Technologies

Ken Gerlach, CDC

Geoffrey Glauser, Geoffrey Glauser, LLC

Dr. Šeila Selimović, NIH

12:15 – 1:15 p.m. Lunch  
1:15 – 1:45 p.m. From Innovation to Implementation: The Journey of a New Shingles Vaccine Dr. Leonard Friedland, GSK
1:45 – 2:30 p.m. New Approaches to Analyzing National Immunization Survey Data Dr. Jim Singleton, CDC
2:30 – 2:45 p.m. Break  
2:45 – 4:15 p.m. Opportunities in HPV Cancer Prevention

Judy Mendel, NVPO

Dr. Jim Singleton, CDC

Dr. Abby Sandler, NCI

Marla Dalton, National Foundation for Infectious Diseases

Jill Wasserman, HHS Office on Women’s Health

Dr. Noel Brewer, National HPV Vaccination Roundtable

4:15 – 4:45 p.m. Public Comment  
4:45 p.m. Adjourn